Details
Product Name in the RMS: Triveram 40 mg/10 mg/10 mg
MR Number: FI/H/0840/005
Date of outcome: 23.07.2015
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Known Active Substance Initial Application Fixed Combination Chemical Substance Prescription Only |
Active Substances |
amlodipine besilate 13,87 mg atorvastatin calcium 43,28 mg perindopril arginine salt 10 mg |
Form | Film coated tablet |
MA Holder in the RMS |
Les Laboratoires Servier 50 rue Carnot 92284 Suresnes Cedex France |
RMS | Finland |
Date of last change | 05.11.2020 |
ATC-Code |
C10BX11 atorvastatin, amlodipine and perindopril |
CMS Country | Domestic Product Name |
---|---|
Austria | Triveram 40 mg/10 mg/10 mg Filmtabletten |
Belgium | LIPERTANCE 40mg/10mg/10mg comprimé pelliculé |
Croatia | Lipertance 40 mg/10 mg/10 mg filmom obložene tablete |
Cyprus | PROALTA FC TABS |
Czech Republic | LIPERTANCE 40 MG/10 MG/10 MG |
Estonia | TRIVERAM 40MG/10MG/10MG |
France | |
Germany | Proalta 40 mg/10 mg/10 mg Filmtabletten |
Greece | TRIVERAM (ex PROALTA) |
Ireland | |
Italy | |
Latvia | Triveram 40 mg/10 mg/10 mg apvalkotās tabletes |
Lithuania | TRIVERAM 40 mg/10 mg/10 mg plėvele dengtos tabletės |
Luxembourg | |
Malta | |
Netherlands | Triveram 40mg/10mg/10mg filmomhulde tabletten |
Portugal | |
Romania | Lipertance 40 mg/10 mg/10 mg comprimate filmate |
Slovak Republic | Lipertance 40 mg/10 mg/10 mg |
Slovenia |
Documents | |
---|---|
PAR: | FI_H_0840_005_PAR.pdf (11.01.2016) |
Finalised Product Information: | FI_H_0840_005_FinalPI_1of4.pdf (01.11.2019) |
Finalised Product Information: | FI_H_0840_005_FinalPI_2of4.pdf (01.11.2019) |
Finalised Product Information: | FI_H_0840_005_FinalPI_3of4.pdf (01.11.2019) |
Finalised Product Information: | FI_H_0840_005_FinalPI_4of4.pdf (01.11.2019) |